Work

Bovine N-Myc and STAT interactor supplementation in experimental BPIV3 models

Year: 2026
Type: article
Abstract: Bovine parainfluenza virus type 3 (BPIV3) contributes to bovine respiratory disease complex, but the role of the interferon-associated host protein N-Myc and STAT interactor (NMI) in BPIV3 infection remains unclear. We evaluated pre-challenge supplementation with bovine NMI (BoNMI) in bovine respiratory-related cells and short-term mouse models. Recombinant TAT-BoNMI was detected in cell-associated samples from bovine bronchial epithelial cells (BBEC) and embryonic bovine tracheal cells (EBTr), with no measurable reduction in viability after short exposure at the selected concentration. BoNMI-treated cells showed lower BPIV3 RNA levels and infectious titers; the titer pattern was not reproduced by TAT-mScarlet. In the BPIV3– Pasteurella multocida type A (PmA) co-challenge model, 2 of 6 untreated mice died during days 0–3, whereas all six BoNMI-treated mice survived. Lung bacterial counts were lower in the treated co-challenge group; histology was assessed qualitatively. BPIV3 V protein exposure was associated with an MG132-sensitive reduction in BoNMI abundance, and BoNMI supplementation was associated with enhanced IFN-β-induced STAT1 phosphorylation. These preliminary findings support further evaluation of BoNMI supplementation in experimental BPIV3 infection. The short-term pre-challenge design and associative signaling findings limit conclusions about therapeutic efficacy and mechanism.
Language: English
Subfield: Immunology
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7234611751
FWCI:
Cites: 22
Cited by:
Related to: 10